The effects of the COVID-19 pandemic on patients with lysosomal storage disorders in Israel

Keyphrases

• Israel 100%
• COVID-19 Pandemic 100%
• Lysosomal Storage Disease 100%
• COVID-19 40%
• Lockdown 40%
• COVID-19 Pandemic Impact 40%
• Pandemic Restrictions 20%
• Medical Center 20%
• Well-being 20%
• Hospital Setting 20%
• Patient Management 20%
• Caregivers 20%
• Disease Progression 20%
• Enzyme Replacement Therapy 20%
• Daily Routines 20%
• Questionnaire Survey 20%
• Virus Infection 20%
• Medical Management 20%
• Causative Agents 20%
• Treatment Adherence 20%
• SARS-CoV-2 Virus 20%
• Oral Therapy 20%
• Rare Diseases 20%
• Change Impact 20%
• Routine Surveillance 20%
• Inborn Errors of Metabolism 20%
• Multisystem Involvement 20%
• Mood Changes 20%
• Parenteral Therapy 20%
• Routine Treatment 20%
• Compliance to Treatment 20%
• Cognitive Deterioration 20%
• Variable Severity 20%
• Multiple Chronic Conditions 20%
• Home Quarantine 20%
• Motor Deterioration 20%
• Treatment Disruption 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Storage Disease 100%
• Lysosome Storage Disease 100%
• Pandemic 50%
• SARS Coronavirus 50%
• Severe Acute Respiratory Syndrome 25%
• Chronic Disease 25%
• Replacement Therapy 25%
• Deterioration 25%
• Virus Infection 25%
• Disease Exacerbation 25%
• Rare Disease 25%
• Inborn Error of Metabolism 25%
• Diseases 25%